Kyle Totaro
About Kyle Totaro
Kyle Totaro is a Senior Scientist II at Entrada Therapeutics, specializing in the purification and analytical characterization of synthetic proteins. He holds a Bachelor of Science in Chemistry from Lycoming College and a Ph.D. in Organic Chemistry from Brown University.
Work at Entrada Therapeutics
Kyle Totaro has been employed at Entrada Therapeutics as a Senior Scientist II since 2020. In this role, he focuses on the purification and analytical characterization of synthetic proteins. His work involves utilizing chromatographic and spectroscopic methods to ensure the quality and efficacy of protein products. His position at Entrada Therapeutics allows him to apply his extensive knowledge in protein chemistry and contribute to the development of innovative therapeutic solutions.
Education and Expertise
Kyle Totaro earned a Bachelor of Science (B.S.) in Chemistry from Lycoming College, where he studied from 2005 to 2009. He furthered his education at Brown University, obtaining a Doctor of Philosophy (Ph.D.) in Organic Chemistry from 2010 to 2014. His academic background provides a solid foundation for his expertise in peptide synthesis and analytical techniques. Totaro has a strong proficiency in purification and analytical characterization of synthetic proteins, which he has developed throughout his career.
Background
Before joining Entrada Therapeutics, Kyle Totaro worked at Amide Technologies as a Founding Scientist from 2017 to 2020. His role involved significant contributions to the company's research initiatives in Cambridge, MA. Prior to that, he served as a Postdoctoral Associate at the Massachusetts Institute of Technology in the Chemistry Department, specifically in the Pentelute Lab, from 2014 to 2016. His early career included a five-year tenure as a Graduate Student at Brown University, where he focused on organic chemistry.
Achievements
Kyle Totaro has contributed to multidisciplinary research projects throughout his career, collaborating with various industrial groups. His work in peptide synthesis and protein characterization has been integral to advancing research initiatives in the field. His experience across multiple prestigious institutions and companies highlights his commitment to scientific innovation and collaboration.